---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-051109"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:34:45.146947+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics issues 1.15M shares at $2.17, terminates GEM SPA and warrant

## Summary
- Sold 1,152,074 shares to GEM at $2.17/share for aggregate $2.5M.
- GEM waived remaining $1.5M commitment fee and terminated outstanding warrant.
- Share purchase agreement with GEM terminated effective December 20, 2024.
- Shares issued in private placement exempt from registration under Section 4(a)(2).

## SEC filing metadata
- accession: 0001493152-24-051109
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 1.02, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000149315224051109/0001493152-24-051109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000149315224051109/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-051109
- JSON: https://secwatch.observer/filing/0001493152-24-051109.json
- Plain text: https://secwatch.observer/filing/0001493152-24-051109.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.